LAG3 and type 1 diabetes mellitus: In a murine model of Type 1 diabetes, signaling through LAG-3 was shown to limit TREG function [80] and it is unclear if antagonistic antibodies that prevent LAG-3 signaling could enhance TREG suppressive function at the same time that they are promoting effector T cell activity.